Jnj 10181457 dihydrochloride
CAS: 544707-20-2
Ref. 3D-UWA70720
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Informação sobre produto
JNJ 10181457 is a modulator of the modulation of acetylcholine and noradrenaline. It binds to an antigen in the brain, which is believed to be involved in Alzheimer's disease. JNJ 10181457 has been studied in clinical trials for the treatment of Alzheimer's disease. This drug also has potential for use as an immunotherapy for autoimmune diseases and cancer. JNJ 10181457 is a wake-promoting agent that interacts with dopamine receptors, but it also has antipsychotic effects due to its binding to H1 receptors. JNJ 10181457 also has anti-hyperactivity properties, which are likely related to its interactions with histamine receptors.
Propriedades químicas
Consulta técnica sobre: 3D-UWA70720 Jnj 10181457 dihydrochloride
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
